Shaanxi Panlong Pharmaceutical Group Limited By Share Dividends and Buybacks
Dividend criteria checks 3/6
Shaanxi Panlong Pharmaceutical Group Limited By Share is a dividend paying company with a current yield of 0.77% that is well covered by earnings.
Key information
0.8%
Dividend yield
-0.08%
Buyback Yield
Total Shareholder Yield | 0.7% |
Future Dividend Yield | 0.8% |
Dividend Growth | 11.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | CN¥0.220 |
Payout ratio | 20% |
Recent dividend and buyback updates
Recent updates
There Is A Reason Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's (SZSE:002864) Price Is Undemanding
Sep 30Shaanxi Panlong Pharmaceutical Group Limited By Share's (SZSE:002864) Shareholders Will Receive A Bigger Dividend Than Last Year
May 31We Think That There Are Some Issues For Shaanxi Panlong Pharmaceutical Group Limited By Share (SZSE:002864) Beyond Its Promising Earnings
May 02Earnings Not Telling The Story For Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SZSE:002864) After Shares Rise 32%
Mar 06Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 002864 has been paying a dividend for less than 10 years.
Growing Dividend: 002864's dividend payments have increased, but the company has only paid a dividend for 7 years.
Dividend Yield vs Market
Shaanxi Panlong Pharmaceutical Group Limited By Share Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (002864) | 0.8% |
Market Bottom 25% (CN) | 0.6% |
Market Top 25% (CN) | 2.2% |
Industry Average (Pharmaceuticals) | 1.7% |
Analyst forecast (002864) (up to 3 years) | 0.8% |
Notable Dividend: 002864's dividend (0.77%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 002864's dividend (0.77%) is low compared to the top 25% of dividend payers in the CN market (2.16%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (20.1%), 002864's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (30.2%), 002864's dividend payments are well covered by cash flows.